European Journal of Immunology · 1993 · 11 citations · 37 references
Life SciencesImmunologyMolecular BiologyGene DeliveryImmunogeneticsMolecular VirologyAntigen PresentationAntigen ProcessingAntigen RecognitionHistocompatibility AntigensMajor Histocompatibility ComplexT Cell ActivationAntigen Processing GenesClass I Histocompatibility AntigensMajor Histocompatibility Complex (Mhc) PresentationMhc Antigen PresentationMhc Class I MoleculesProcessing Of Viral AntigensTap-mediated Peptide TransportViral Antigen Recognition
The protein products of the Tap (Transporter associated with antigen processing) 1 and 2 genes are presumed to deliver peptides across the endoplasmic reticulum (ER) for assembly with major histocompatibility complex (MHC) class I molecules. The antigen processing-defective cell line RMA-S (H-2b) has a premature stop in the Tap 2 gene and probably therefore fails to deliver peptides into the ER, which leads to a low level of cell surface MHC class I molecules. Transfection of a Tap 2 gene restores to RMA-S both MHC class I molecule expression and the ability to present influenza viral antigens. We investigated the ability of RMA-S cells transfected with a Tap 2 gene to process and present alloantigens, Sendai and Rauscher viral antigens to allogeneic and virus-specific cytotoxic T lymphocytes. We found that allogeneic peptides as well as Rauscher and Sendai viral peptides can be processed and presented by RMA-S but at reduced levels. Transfection of a Tap 2 gene of mouse (BALB/c, H-2d) or rat origin into RMA-S increased the presentation of Sendai viral antigens and partially restored the presentation of allogeneic antigens. The already low level of Rauscher viral peptides presented by RMA-S is not elevated by transfection of either Tap 2 gene into RMA-S. This indicates a differential effect of transfection of a Tap 2 gene of rat or allogeneic mouse origin into RMA-S on viral antigen processing.
37
Structure of the human class I histocompatibility antigen, HLA-A2
Pamela J. Björkman, Mark A. Saper, Boudjéma Samraoui et al. · Nature · 1987 · 3.5K citations
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Klas Kärre, Hans Ljunggren, Gerald E. Piontek et al. · Nature · 1986 · 2.1K citations
Life Sciences, Immunology, Oncology +12
Association of class I major histocompatibility heavy and light chains induced by viral peptides
Alain Townsend, Claes Öhlén, Judy Bastin et al. · Nature · 1989 · 990 citations